LQDA Liquidia Corporation
$25.91 -6.26%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-6.26%
YTD
+7.80%
P/E
18.5
P/B
12.93
ROE
149.6%
Div yield
—
Beta
0.9
Market cap
$2.6B
RSI (14)
19
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$27.95
Close
$25.91
VWAP (n/a)
—
Day high
$28.30
Day low
$25.76
Volume
5.3M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Stocktwits Wall Street Wrap: Analysts Turn Bullish On Sweetgreen, Target And Airbnb – Liquidia And FICO Face Downgrades
Yahoo Finance · Oct 2
United Therapeutics Just Sent Liquidia Stock Lower After Patent Battle
Yahoo Finance · Oct 1
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet
Yahoo Finance · Oct 1
LQDA Stock On Track For Worst Week Ever As Analysts Say The Yutrepia Patent Loss Clouds Its Path
Yahoo Finance · Oct 1
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback
Yahoo Finance · Oct 1
United Therapeutics Won Its Patent War and Liquidia Collapsed
Yahoo Finance · Oct 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 30, 2026 View → 8-K Sep 3, 2026 View → 10-Q Aug 12, 2026 View → 8-K Aug 12, 2026 View → 8-K Jun 17, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell LQDA. Try it in the Lab to size a position and see the risk.